Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023380 (
lethargy
)
5,697
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A 19-month-old entire male French lop rabbit was presented with a two-week history of a depressed appetite and
lethargy
. Clinical and laboratory findings, together with abdominal radiographic studies, suggested a diagnosis of right-sided calcium
ureterolithiasis
. Management included the surgical removal and analysis of the urolith. Confirmation of a calcium-containing urolith and the presence of hypercalcaemia necessitated the introduction of a low calcium diet. Recovery was complicated by the occurrence of a second urolith within the left ureter. This was also removed successfully by surgical means. The rabbit made a full recovery and assessment of serial serum calcium concentration has since confirmed the long-term maintenance of calcium levels within their normal range.
...
PMID:Management of calcium ureterolithiasis in a French lop rabbit. 1179 74
A 6-year-old female spayed Domestic Shorthair cat was presented with acute
lethargy
, dehydration, marked azotemia, metabolic acidosis, left-sided renomegaly, and bilateral hydronephrosis.
Ureterolithiasis
and ureteral obstruction were suspected based on further diagnostics including abdominal sonography. Medical treatment was not successful. Fluoroscopically guided antegrade pyelography confirmed the diagnosis of bilateral ureteral obstruction due to
ureterolithiasis
. Subcutaneous ureteral bypass (SUB) devices were placed bilaterally, followed by close patient monitoring. Frequent reassessment of patient parameters and blood work served to adjust the fluid needs of the patient and to ensure proper hydration, correction of azotemia at an appropriate rate, and cardiovascular stability. After significant improvement of all patient parameters within 5 days, the patient was discharged from the hospital. Treatment included a dietary change to reduce the risk of stone formation as well as a phosphorus binder. Clinical and clinicopathologic parameters were unchanged at the 1- and 4- and 7-month rechecks (consistent with IRIS CKD stage II-NP-AP0), and both SUB devices continued to provide unobstructed urine flow. Bilateral placement of subcutaneous ureteral bypass devices may be a safe and potentially effective treatment option for acute bilateral ureteral obstruction in cats with
ureterolithiasis
. Strict patient monitoring and patient-centered postoperative treatment decisions are crucial to successful treatment outcomes.
...
PMID:[Subcutaneous ureteral bypass devices as a treatment option for bilateral ureteral obstruction in a cat with ureterolithiasis]. 2689 28